Refining TIL Therapy through Selective Expansion & Genetic Engineering
- Isolating tumor-reactive TIL using phenotypic markers to enhance therapeutic specificity
- Engineering selected TIL with viral constructs to boost potency and persistence
- Expanding enriched TIL populations in optimized culture conditions to improve product quality